January 22, 2026Key Drug Discovery ArticlesComments Off on Targeting EGFR Drug Resistance in NSCLC: Identification of Alternative Inhibitors through Structural Analysis and Virtual Screening
December 14, 2025Key Drug Discovery ArticlesComments Off on RY103: A Novel IDO1 Inhibitor Targeting Immune Suppression and Angiogenesis in Glioblastoma Therapy
August 23, 2025Key Drug Discovery ArticlesComments Off on Unexpected Impact of Roxadustat on Thyroid Function: New Insights into HIF-PH Inhibitors in Renal Anemia
August 22, 2025Key Drug Discovery ArticlesComments Off on Splicing modulating small molecules perturb the entire transcriptome: implications for developing next generation therapies for spinal muscular atrophy
June 21, 2025Key Drug Discovery ArticlesComments Off on Comprehensive Pharmacokinetic Analysis of Brepocitinib Using a 14C-Microtracer Approach in Healthy Male Subjects: A Phase 1 ADME Study
June 19, 2025Key Drug Discovery ArticlesComments Off on Gepotidacin: A Novel Triazaacenaphthylene Antibacterial with Dual-Targeting Mechanism Against E. coli Gyrase and Topoisomerase IV
December 24, 2024Key Drug Discovery ArticlesComments Off on ADS032: A Dual Inhibitor of NLRP1 and NLRP3 Inflammasomes – A Game-Changer in Inflammatory Disease Research and Therapy